본문 바로가기
KERD
논문KCI 등재

소아 피부 및 연조직 감염 환자에서의 황색포도알균의 항생제 감수성의 변화: 2010년부터 2018년까지 단일기관에서의 경험

Changing Susceptibility of Staphylococcus aureus in Children with Skin and Soft Tissue Infections: a Single Center Experience from 2010 to 2018

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

목적: 피부 및 연조직 감염(skin and soft tissue infections [SSTIs])의 가장 흔한 원인은 황색포도알균(Staphylococcus aureus)이다. 본 연구는 19세 미만의 SSTI 환자에서 분리된 황색포도알균의 항생제 감수성의 변화추이를 알아보고자 하였다. 방법: 황색포도알균이 분리된 소아청소년 지역사회관련 SSTI 환자에서 후향적 관찰연구를 시행하였다. 미생물학 및 인구학적 자료를 수집하고, 항생제 감수성의 변화추이를 관찰하였다. 결과: 2010년 1월부터 2018년 12월까지 총 807개의 지역사회관련 황색포도알균이 연구에 포함되었다. Oxacillin에 대한 감수성은 전반적으로 증가하여(P<0.001) 2018년에는 75.0%였다. Trimethoprim/sulfamethoxazole과 tetracycline에 대한 감수성은 매우 높게 유지되어 2018년 각각 97.6%와 95.2%였다. 만 1–5세 연령군에서 만 6–18세 연령군에 비해 oxacillin 감수성이 유의하게 낮았다(53.4% vs. 75.0%, P<0.001). 결론: 소아청소년의 지역사회관련 SSTI의 원인이 된 황색포도알균 중 메티실린내성 황색포도알균의 비율이 감소하고 있는 것으로 보인다. 임상의는 경험적 항생제를 선택할 때 지역적 항생제 감수성 양상을 확인해야 한다.

Abstract

Purpose: Staphylococcus aureus is a major cause of skin and soft tissue infections (SSTIs). This study aimed to determine the temporal trends in antibiotic susceptibility of S. aureus in SSTI patients aged <19 years. Methods: This retrospective observational study was conducted in pediatric patients with SSTI caused by community-associated S. aureus. Microbiologic and demographic data were collected, and the trends of antibiotic susceptibility results were evaluated. Results: From January 2010 to December 2018, a total of 807 S. aureus isolates were included. An overall increase in susceptibility of isolates to oxacillin was noted (P<0.001), with 75.0% of isolates being oxacillin-susceptible in 2018. S. aureus remained highly susceptible to trimethoprim/sulfamethoxazole and tetracycline, with 97.6% and 95.2% isolate susceptibility in 2018, respectively. Isolates from younger children aged 1 to 5 years had a significantly lower rate of susceptibility to oxacillin than older children aged 6 to 18 years (53.4% vs. 75.0%, P<0.001). Conclusions: The proportion of methicillin-resistant S. aureus isolates appears to decrease in pediatric patients with community-associated SSTI caused by S. aureus. Clinicians should be aware of regional susceptibility patterns when choosing empirical regimens.

참고문헌 (29)

  1. Moet GJ, "Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004)", Diagn Microbiol Infect Dis, 57, pp.7~13 (2007)
  2. Edelsberg J, "Trends in US hospital admissions for skin and soft tissue infections", Emerg Infect Dis, 15, pp.1516~1518 (2009)
  3. Pallin DJ, "Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus", Ann Emerg Med, 51, pp.291~298 (2008)
  4. Chuang YY, "Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia", Lancet Infect Dis, 13, pp.698~708 (2013)
  5. Ma SH, "Meticillin-resistant Staphylococcus aureus clones with distinct clinical and microbiological features in a Korean community", J Med Microbiol, 56, pp.866~868 (2007)
  6. 최영준, "소아 황색포도알균 감염증의 임상양상에 대한 고찰: 지역사회 관련 메티실린 내성 황색포도알균 감염을 중심으로", Pediatric Infection and Vaccine, 16(2), pp.150~161 (2009), 대한소아감염학회
  7. Velasco D, "Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus", J Antimicrob Chemother, 55, pp.379~382 (2005)
  8. Klein E, "Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005", Emerg Infect Dis, 13, pp.1840~1846 (2007)
  9. Landrum ML, "Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010", JAMA, 308, pp.50~59 (2012)
  10. Sutter DE, "Changing susceptibility of Staphylococcus aureus in a US pediatric population", Pediatrics, 137, pp.e20153099~ (2016)
  11. Johnson AP, "Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years", J Antimicrob Chemother, 67, pp.802~809 (2012)
  12. European Centre for Disease Prevention and Control, "Antimicrobial resistance (EARS-Net)", ECDC. Annual epidemiological report for 2014, pp.1~14 (2018), ECDC
  13. Moon HW, "Antimicrobial susceptibility profiles of Staphylococcus aureus isolates classified according to their origin in a tertiary hospital in Korea", Am J Infect Control, 42, pp.1340~1342 (2014)
  14. Kim ES, "Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea", PLoS One, 9, pp.e114127~ (2014)
  15. Baek YS, "Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea", Int J Dermatol, 55, pp.e191~e197 (2016)
  16. 임선희, "단일 기관에서 2002년부터 2016년까지 발생한 소아 황색포도알균 균혈증의 역학", Pediatric Infection and Vaccine, 26(1), pp.11~21 (2019), 대한소아감염학회[DOI]
  17. 신선미, "Prevalence of Antibiotic Use for Pediatric Acute Upper Respiratory Tract Infections in Korea", Journal of Korean Medical Science, 30(5), pp.617~624 (2015), 대한의학회
  18. 박정민, "Change in Antimicrobial Susceptibility of Skin-Colonizing Staphylococcus aureus in Korean Patients with Atopic Dermatitis during Ten-Year Period", Annals of Dermatology, 28(4), pp.470~478 (2016), 대한피부과학회
  19. 황윤하, "아토피피부염 소아의 피부집락균 중 Staphylococcus aureus 의 빈도와 항생제 감수성에 관한 연구", Allergy Asthma & Respiratory Disease, 5(1), pp.21~26 (2017), 대한 소아알레르기 호흡기학회[DOI]
  20. Kaplan SL, "Treatment of community-associated methicillin-resistant Staphylococcus aureus infections", Pediatr Infect Dis J, 24, pp.457~458 (2005)
  21. Stevens DL, "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America", Clin Infect Dis, 59, pp.147~159 (2014)
  22. Herigon JC, "Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999–2008", Pediatrics, 125, pp.e1294~e1300 (2010)
  23. Khamash DF, "Increasing clindamycin and trimethoprim-sulfamethoxazole resistance in pediatric Staphylococcus aureus infections", J Pediatric Infect Dis Soc, 8, pp.351~353 (2019)
  24. Song YK, "A national pharmacoepidemiological study of antibiotic use in Korean paediatric outpatients", Arch Dis Child, 102, pp.660~666 (2017)
  25. Levi N, "Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis", Pediatrics, 123, pp.e297~e304 (2009)
  26. Williams DJ, "Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections", Pediatrics, 128, pp.e479~e487 (2011)
  27. Miller LG, "Clindamycin versus trimethoprimsulfamethoxazole for uncomplicated skin infections", N Engl J Med, 372, pp.1093~1103 (2015)
  28. Grossman ER, "Tetracyclines and permanent teeth: the relation between dose and tooth color", Pediatrics, 47, pp.567~570 (1971)
  29. Friedman ND, "The negative impact of antibiotic resistance", Clin Microbiol Infect, 22, pp.416~422 (2016)

관련 논문AI추천

이 간행물의 다른 논문 (8건)